Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-asparaginase Plus DICE in Stage I/II NK/T-cell Lymphoma
NCT00933673Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jun 2009
- Primary completion
- Jun 2012
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of asparaginase escherichia coli in Natural killer T-cell lymphoma (NKTL), sponsored by Fudan University. Status: unknown.
02
Drugs
asparaginase escherichia coli
03
Conditions
Natural killer T-cell lymphoma (NKTL)
Beyond the preview
Go deeper on NCT00933673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00933673.